Search Results - Garosi, Vittorio

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

    Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial by Argilés, Guillem, Saunders, Mark P, Rivera, Fernando, Sobrero, Alberto, Benson, Al, Guillén Ponce, Carmen, Cascinu, Stefano, Van Cutsem, Eric, Macpherson, Iain R, Strumberg, Dirk, Köhne, Claus-Henning, Zalcberg, John, Wagner, Andrea, Luigi Garosi, Vittorio, Grunert, Julia, Tabernero, Josep, Ciardiello, Fortunato

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer

    Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer by Van Laethem, Jean-Luc, Riess, Hanno, Jassem, Jacek, Haas, Michael, Martens, Uwe M., Weekes, Colin, Peeters, Marc, Ross, Paul, Bridgewater, John, Melichar, Bohuslav, Cascinu, Stefano, Saramak, Piotr, Michl, Patrick, Van Brummelen, David, Zaniboni, Alberto, Schmiegel, Wollf, Dueland, Svein, Giurescu, Marius, Garosi, Vittorio L., Roth, Katrin, Schulz, Anke, Seidel, Henrik, Rajagopalan, Prabhu, Teufel, Michael, Childs, Barrett H.

    Published in Targeted oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 5239: KRAS wild-type status as detected by circulating tumor DNA analysis may be a prognostic or predictive factor for clinical benefit in patients with unresectable, locally advanced or metastatic pancreatic cancer (PC) treated with the MEK inhibitor refametin

    Abstract 5239: KRAS wild-type status as detected by circulating tumor DNA analysis may be a prognostic or predictive factor for clinical benefit in patients with unresectable, loca... by Teufel, Michael, Van Laethem, Jean-Luc, Riess, Hanno, Giurescu, Marius, Garosi, Vittorio L., Schulz, Anke, Vonk, Richardus, Seidel, Henrik, Reischl, Joachim, Childs, Barrett H.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Pharmacological antagonism of lipoprivic feeding induced by sodium mercaptoacetate

    Pharmacological antagonism of lipoprivic feeding induced by sodium mercaptoacetate by Garosi, Vittorio L., Nisoli, Enzo, Blundell, John E., Carruba, Michele O.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Salbutamol antagonizes insulin- and sodium mercaptoacetate-induced but not 2-deoxy- d-glucose-induced hyperphagia

    Salbutamol antagonizes insulin- and sodium mercaptoacetate-induced but not 2-deoxy- d-glucose-induced hyperphagia by Nisoli, Enzo, Garosi, Vittorio, Blundell, John E., Carruba, Michele O.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Catecholamine and serotonin depletion from rat spinal cord: Effects on morphine and footshock induced analgesia

    Catecholamine and serotonin depletion from rat spinal cord: Effects on morphine and footshock induced analgesia by Carruba, Michele O., Nisoli, Enzo, Garosi, Vittorio, Sacerdote, Paola, Panerai, Alberto E., Da Prada, Mosè

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Central nervous system involvement in elderly patients with non-insulin-dependent diabetes mellitus

    Central nervous system involvement in elderly patients with non-insulin-dependent diabetes mellitus by Cerizza, Massimo, Minciotti, Giuseppe, Meregalli, Stefania, Garosi, Vittorio, Crosti, Pier Franco, Frattola, Lodovico

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: